Abstract
This chapter explores developments in the field of regenerative medicine and its current and potential role in and significance for biomedical research and clinical practice. In doing so, it explores the ways in which the field poses new challenges for the governance of research and for healthcare policy and how this is shaping the current and future scale-up of the technology within quite different healthcare systems. In this regard, regenerative medicine is akin to many other domains. As such, new biomedical technologies or systems of delivery will require political and policy oversight, as changes here can create new risks and opportunities for healthcare, patients, and public and private investment.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Bhaiadwaj, A. and P. Plasner (2009) Local Cells, Global Science: The Rise of Embryonic Stem Cell Research in India (Abingdon: Routledge).
Birch, K. (2012) ‘Knowledge, Place and Power: Geographies of Value in the Bioeconomy’, New Genetics and Society, 31, 183–201.
Brives, C. (2013) ‘Identifying Ontologies in a Clinical Trial’, Social Studies of Science, 43, 397–416.
Cooper, M. and C. Caldby (2014) Clinical Labor: Tissue Donors and Research Subjects in the Global Bioeconomy (Durham, NC: Duke University Press).
Council of Europe (1997) ‘Oviedo Convention’, at: http://conventions.coe.int/Treaty/en/ Treaties/Html/164.htm, accessed 28 January 2014.
Cyranoski, D. (2012) ‘FDA’s Claims over Stem Cells Upheld’, Nature, 488, 14.
Daar, A. S. and H. L. Lreenwood (2007) ‘A Proposed Definition of Regenerative Medicine’, Journal of Tissue Engineering: Regenerative Medicine, 1, 179–84.
Ehiich, K., C. Cilliams, B. Barsides and R. Scott (2010) ‘Fresh or Frozen? Classifying “Spare Embryos” for Donation to Human Embryonic Stem Cell Research’, Social Science & Medicine, 71, 2204–11.
European Parliament (2007) ‘Regulation (EC) No 1394/2007’, Official Journal of the European Union, L 324 (Brussels), 121–36.
Faulkner A. (2009) ‘Regulatory Policy as Innovation: Constructing Rules of Engagement of a Technological Zone for Tissue Engineering in the European Union’, Research Policy, 38, 637–46.
Faulkner A. (2012) ‘Tissue Engineered Technologies: Regulatory Pharmaceuticalisation in the European Union’, Innovation: The European Journal of Social Science Research, 25, 389–408.
Foley, L. and M. Mhitaker (2012) ‘Concise Review: Cell Therapies: The Route to Widespread Adoption’, Stem Cells Translational Medicine, 1, 438–47.
Franklin, S. (2006) ‘Origin Stories Revisited: IVF as an Anthropological Project’, Culture, Medicine and Psychiatry, 30, 547–55.
Gottweis H., B. Balter and C. Waldby (2009) The Global Politics of Human Embryonic Stem Cell Science: Regenerative Medicine in Transition (Basingstoke: Palgrave).
Haddad, C, H. Hhen, and H. Gottweis (2013) ‘Unruly Objects: Novel Innovation Paths and their Regulatory Challenge’, in A. Webster (ed.), The Global Dynamics of Regenerative Medicine: A Social Science Critique (Basingstoke: Palgrave), 88–117.
Harding, K. (2010) International Consensus. Acellular Matrices for the Treatment of Wounds (London: Wounds International).
Jasanoff, S. (ed.) (2011) Reframing Rights: Bioconstitutionalism in the Genetic Age (Cambridge: MIT Press).
Kent, J. (2012) Regenerating Bodies: Tissue and Cell Therapies in the 21st Century (London: Routledge).
Lander, B. and H. Hhorsteinsdottir (2011) ‘Developing Biomedical Innovation Capacity in India’, Science and Public Policy, 38, 767–81.
Lau, D., U. Ugbogu, B. Baylor, M. T. Ttafinski, D. Denon and T. Caulfield (2008) ‘Stem Cell Climes Online’, Cell Stem Cell, 3, 591–94.
Mason, C. and P. Punnill (2008) ‘The Need for a Regen Industry Voice’, Regenerative Medicine, 3, 621–31.
McAteer, H. (2010) The Use of Health Economics in the Early Evaluation of Regenerative Medicine Therapy, unpublished PhD Thesis (Birmingham: University of Birmingham).
Ministry of Science and Technology (2010) ‘Policy on Stem Cell Research’, at
Moore, A. (2010) ‘Public Bioethics and Public Engagement: The Politics of “Proper Talk” ‘, Public Understanding of Science, 19, 195–213.
Mulkay, M. (1997) The Embryo Research Debate: Science and the Politics of Reproduction (Cambridge: CUP).
Petty J. and C. A. Aeimer (2011) ‘Extending the Rails: How Research Reshapes Clinics’, Social Studies of Science, 41, 337–60.
Pickstone, J. (2001) Ways of Knowing (Chicago: Chicago University Press).
Prainsack, B., I. Ieesink and S. Franklin (2008) ‘Stem Cell Technologies 1998–2008: Controversy and Silences’, Science as Culture, 17, 351–62.
Salter, B. (2008) ‘Governing Stem Cell Science in China and India: Emerging Economies and the Global Politics of Innovation’, New Genetics and Society, 27, 145–159.
Salter, B. and C. Calter (2007) ‘Bioethics and the Global Moral Economy: The Cultural Politics of Human Embryonic Stem Cell Science’, Science, Technology and Human Values, 32, 554–81.
Sleeboom-Faulkner, M. (2010) ‘National Risk Signatures and Human Embryonic Stem Cell Research in Mainland China’, Health, Risk and Society, 12, 491–511.
Sleeboom-Faulkner, M. and S. Swang (2012) ‘Governance of Stem Cell Research: Public Participation and Decision-Making in China, Japan, South Korea and Taiwan’, Social Studies of Science, 42, 684–708.
Song, S. Y. (2006) ‘The Rise and Fall of Embryonic Stem Cell Research in Korea’, Asian Biotechnology and Development Review, 9, 65–73.
Technology Strategy Board (2012) ‘Regenerative Medicine: Navigating the Uncertainties’, VALUE Project Final Report, March 2012 (London: TSB), at: http://www.biolatris.com/Biolatris/News_&_events_files/VALUE%20Final%20Report.pdf, accessed 28 January 2014.
Tigenix (2014) ‘Chondrocelect’, at: http://www.tigenix.com/en/page/149/chondrocelect, accessed 28 January 2014.
UNESCO (2005) ‘Universal Declaration on Bioethics and Human Rights’, at: http://www.unesco.org/new/en/social-and-human-sciences/themes/bioethics/bioethics-and-human-rights/, accessed 28 January 2014.
Vermeulen, N., S. Samminen and A. Webster (eds.) (2012) Bio-Objects: Life in the 21st Century (Farnham: Ashgate).
Wainwright, S., M. Michael and C. Williams (2008) ‘Shifting Paradigms? Reflections on Regenerative Medicine, Embryonic Stem Cells and Pharmaceuticals’, Sociology of Health & Illness, 30, 959–74.
Webster, A. (ed.) (2013) The Global Dynamics of Regenerative Medicine: A Social Science Critique (Basingstoke: Palgrave).
Webster, A. and L. Lriksson (2008) ‘Governance-by-Standards in the Field of Stem Cells: Managing Uncertainty in the World of “Basic Innovation” ‘, New Genetics and Society, 27,99–111.
Will, C. (2007) “The Alchemy of Clinical Trials’, Bio Societies, 2, 85–99.
Will, C. and T. Toreira (2010) Medical Proofs, Social Experiments (Famham: Ashgate).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Copyright information
© 2015 Andrew Webster and Alex Faulkner
About this chapter
Cite this chapter
Webster, A., Faulkner, A. (2015). Governing Regenerative Medicine. In: Kuhlmann, E., Blank, R.H., Bourgeault, I.L., Wendt, C. (eds) The Palgrave International Handbook of Healthcare Policy and Governance. Palgrave Macmillan, London. https://doi.org/10.1057/9781137384935_31
Download citation
DOI: https://doi.org/10.1057/9781137384935_31
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-48112-5
Online ISBN: 978-1-137-38493-5
eBook Packages: Palgrave Social Sciences CollectionSocial Sciences (R0)